|
FMNL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62825308791525E-12 |
| Normal-vs-Stage2 |
1.58958999999514E-05 |
| Normal-vs-Stage3 |
6.87519999820196E-08 |
| Normal-vs-Stage4 |
5.815200E-04 |
| Stage1-vs-Stage2 |
4.056300E-02 |
| Stage1-vs-Stage3 |
8.666400E-01 |
| Stage1-vs-Stage4 |
5.507400E-01 |
| Stage2-vs-Stage3 |
1.011250E-01 |
| Stage2-vs-Stage4 |
4.153800E-01 |
| Stage3-vs-Stage4 |
5.368600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.51950008131507E-10 |
| Normal-vs-Asian |
9.502100E-02 |
| Caucasian-vs-AfricanAmerican |
8.909800E-01 |
| Caucasian-vs-Asian |
5.002200E-01 |
| AfricanAmerican-vs-Asian |
5.067400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.59872115546023E-14 |
| Male-vs-Female |
1.916600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.78989999991097E-08 |
| Normal-vs-Extreme_Weight |
1.63224989080391E-12 |
| Normal-vs-Obese |
6.04860050934519E-10 |
| Normal-vs-Extreme_Obese |
4.984200E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.917400E-01 |
| Normal_Weight-vs-Obese |
1.878010E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.053800E-01 |
| Extreme_Weight-vs-Obese |
1.000980E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.490400E-01 |
| Obese-vs-Extreme_Obese |
8.679600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.94420000002127E-06 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64968039229052E-12 |
| Normal-vs-Age(81-100Yrs) |
1.048760E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.594100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.126380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.894400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.810400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.241000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
8.92899998383712E-09 |
| Normal-VS-KIRP CIMP |
8.24820000000503E-05 |
| Normal-VS-Unclassified PRCC |
2.40880000390575E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.742770E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.761000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.145400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.672220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.682030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.746800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84000001293805E-09 |
| Normal-vs-N1 |
2.53029999952581E-07 |
| Normal-vs-N2 |
9.809800E-02 |
| N0-vs-N1 |
5.403900E-02 |
| N0-vs-N2 |
3.307200E-01 |
| N1-vs-N2 |
9.816400E-01 |
|
|
